[Stiff-man syndrome from neurological perspective].
Meinck
H M
HM
Neurologische Universitätsklinik Heidelberg. hans-michael_meinck@med.uni-heidelberg.de
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001323:Autoantibodies / Q000276:immunology*; D001327:Autoimmune Diseases / Q000453:epidemiology; D001569:Benzodiazepines; D015897:Comorbidity; D003937:Diagnosis, Differential; D005858:Germany / Q000453:epidemiology; D005968:Glutamate Decarboxylase / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D011379:Prognosis; D016750:Stiff-Person Syndrome / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology / Q000276:immunology
D014151:Anti-Anxiety Agents; D001323:Autoantibodies; D007166:Immunosuppressive Agents; D009125:Muscle Relaxants, Central; D001569:Benzodiazepines; D005968:Glutamate Decarboxylase
Das Stiff-Man-Syndrom aus neurologischer Sicht.